Binding of O-Alkyl Derivatives of Serotonin at Human 5-HT1Dβ Receptors
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 39 (1) , 314-322
- https://doi.org/10.1021/jm950498t
Abstract
In humans, 5-HT1D serotonin receptors represent terminal autoreceptors, and there is some evidence that 5-HT1D ligands may be useful in the treatment of migraine. The most widely used 5-HT1D agonist is sumatriptan; however, this agent reportedly displays little selectivity for 5-HT1D versus 5-HT1A receptors. To identify novel serotonergic agents with enhanced 5-HT1D versus 5-HT1A selectivity, we attempted to take advantage of possible differences in the regions of bulk tolerance associated with the 5-position of the 5-HT binding sites for these two populations of receptors. Examination of a series of 5-(alkyloxy)tryptamine derivatives demonstrated that compounds with unbranched alkyl groups of up to eight carbon atoms bind with high affinity at human 5-HT1Dβ receptors (Ki < 5 nM) but demonstrate less than 50-fold selectivity relative to 5-HT1A receptors. Alkyl groups longer than eight carbon atoms impart reduced affinity for 5-HT1A receptors whereas groups longer than nine carbon atoms lead to compounds with reduced affinity at 5-HT1Dβ receptors. 5-(Nonyloxy)tryptamine (10) represents a compound with optimal 5-HT1Dβ affinity (Ki = 1 nM) and selectivity (>300-fold). Branching of the alkyl chain, to 5-[(7,7-dimethylheptyl)oxy]tryptamine (15), results in an agent with somewhat lower affinity (5-HT1Dβ Ki = 2.3 nM) but with greater (i.e., 400-fold) 5-HT1D versus 5-HT1A selectivity. Replacement of the oxygen atom of 10 with a methylene group (i.e., 20), replacement of the O-proximate methylene with a carbonyl group (i.e., ester 26), or cyclization of the aminoethyl moiety to a carbazole (e.g., 34, 36) or β-carboline (i.e., 37), result in reduced affinity and/or selectivity. None of the compounds examined displayed significant selectivity for 5-HT1Dβ versus 5-HT1Dα sites; nevertheless, compounds 10 (recently shown to behave as a 5-HT1D agonist) and 15 represent the most 5-HT1D versus 5-HT1A selective agents reported to date.Keywords
This publication has 17 references indexed in Scilit:
- In situ hybridization evidence for the synthesis of 5‐HT1B receptor in serotoninergic neurons of anterior raphe nuclei in the rat brainSynapse, 1995
- 5-[(3-Nitropyrid-2-yl)amino]indoles: Novel Serotonin Agonists with Selectivity for the 5-HT1D Receptor. Variation of the C3 Substituent on the Indole Template Leads to Increased 5-HT1D Receptor SelectivityJournal of Medicinal Chemistry, 1994
- Evolution of a Novel Series of [(N,N-Dimethylamino)propyl]- and Piperazinylbenzanilides as the First Selective 5-HT1D AntagonistsJournal of Medicinal Chemistry, 1994
- 5‐HT1D serotonin receptors: Results of a structure‐affinity investigationDrug Development Research, 1991
- Serotonin 5‐HT1D Receptors in Human Prefrontal Cortex and Caudate: Interaction with a GTP Binding ProteinJournal of Neurochemistry, 1988
- Cephalosporin derivatives with 2- and 4-pyridone groups at carbon-3Journal of Medicinal Chemistry, 1979
- Aminohaloborane in organic synthesis. 2. Simple synthesis of indoles and 1-acyl-3-indolinones using specific ortho .alpha.-chloroacetylation of anilinesThe Journal of Organic Chemistry, 1979
- 3-Aminotetrahydrocarbazoles as a new series of central nervous system agentsJournal of Medicinal Chemistry, 1977
- Application of nonenzymic biogenetic-like olefinic cyclizations to the total synthesis of dl-serratenediolJournal of the American Chemical Society, 1974
- Branched-Chain Fatty Acids. I. Synthesis of 17-Methyloctadecanoic AcidJournal of the American Chemical Society, 1942